Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44

United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$612.07K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$90.68M

$9.77M on a plan · $32.21M straight out of an exercise

Sold at will

$48.70M

149 of 234 sales

Net

−$90.07M

−$48.09M against sales at will